EntryPoint Capital’s Verona Pharma VRNA Stock Holding History

EntryPoint Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,125
2024 Q3	$406K	Buy	+14,125
2024 Q2	–	Sell	-1,175
2024 Q1	$18.9K	Buy	+1,175